Often a pharmaceutical or biotech company re-allocates resource so that they can concentrate on other medicines in their portfolio. They also have a commitment to provide patients with the medicines they need.
That’s where Clinigen comes in, acquiring medicines to make sure that patients in need continue to get access. Maintaining pharma companies’ standards, safeguarding their reputation, and enabling them to focus on their key priorities.
Clinigen utilise their footprint and global expertise built on 30 years of invaluable local insights to maintain and grow supply through a range of different commercial and unlicensed channels.
That’s why Clinigen clients can be confident they get the result that’s right for them and for their customers, and ultimately for their patients.